InflaRx (IFRX) Accumulated Expenses (2022 - 2025)

InflaRx's Accumulated Expenses history spans 3 years, with the latest figure at $2.2 million for Q4 2024.

  • For Q4 2024, Accumulated Expenses rose 27.38% year-over-year to $2.2 million; the TTM value through Dec 2024 reached $2.2 million, up 27.38%, while the annual FY2024 figure was $2.2 million, 28.33% up from the prior year.
  • Accumulated Expenses for Q4 2024 was $2.2 million at InflaRx, up from $1.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $2.2 million in Q4 2024 and bottomed at $1.3 million in Q4 2022.
  • The 3-year median for Accumulated Expenses is $1.7 million (2023), against an average of $1.8 million.
  • The largest annual shift saw Accumulated Expenses grew 29.37% in 2023 before it increased 27.38% in 2024.
  • A 3-year view of Accumulated Expenses shows it stood at $1.3 million in 2022, then grew by 29.37% to $1.7 million in 2023, then increased by 27.38% to $2.2 million in 2024.
  • Per Business Quant, the three most recent readings for IFRX's Accumulated Expenses are $2.2 million (Q4 2024), $1.7 million (Q4 2023), and $1.3 million (Q4 2022).